CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly licensed Geenius test is an immunochromatographic assay designed to confirm and differentiate individual antibodies to Human Immunodeficiency Virus Types 1 and 2. The assay will be replacing the HIV-1 Western blot and HIV-2 EIA assays which are performed on samples with a reactive result on a licensed HIV 1/2 screening test.
Read all about it on the Communication page by clicking this link: Communications
We have now added a new section called the "Assay History List" to the "At A Gla...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...